Clinical trial

Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

NCT02644044

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-01-01

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2015-12-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MSunresolved

Interventions

Intrathecal methotrexateDRUG

Sponsors & collaborators

Tel-Aviv Sourasky Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02644044 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.